Stryker Management Trio Poised To Restore 20% Earnings Growth By 2000
This article was originally published in The Gray Sheet
Stryker's ability to successfully integrate Howmedica and return to historical earnings growth (20% annually the past two decades) by 2000 rests largely in the hands of three recently appointed Group Presidents - Ronald A. Elenbaas (Med-Surg), Edward "Ned" Lipes (Howmedica Osteonics U.S.) and Jack O'Mahony (Stryker International).
You may also be interested in...
Stryker Instruments anticipates retrieving within 30 days certain lots of Heavy Duty blades recalled because of a "slight potential" for package failure that could affect the sterility of the devices.
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.